Tempus Launches New Precision Medicine-Driven Tests: Tempus|HRD and Tempus|TO
May 31, 2020 10:30 ET
|
Tempus
CHICAGO, May 31, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, announced the launch...
Tempus’ TIME Trial™ Program Reaches Critical Scale and Operational Milestones
May 29, 2020 15:55 ET
|
Tempus
CHICAGO, May 29, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has reached a...
Tempus Announces the Appointment of Scott Gottlieb, MD, to Its Board of Directors
October 29, 2019 11:00 ET
|
Tempus
CHICAGO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announced that...
Nature Biotechnology Study Reveals That Tempus’ xT Platform Increases Cancer Patients’ Personalized Therapeutic Opportunities
September 30, 2019 11:00 ET
|
Tempus
CHICAGO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today published a...
Tempus Expands Leadership Team With the Appointment of Joel Dudley, PhD, as Senior Vice President of Research
August 22, 2019 12:00 ET
|
Tempus
CHICAGO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announces the...
Tempus and Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas
June 11, 2019 08:00 ET
|
Tempus
CHICAGO, June 11, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale announced today that...
Tempus Announces (TIME) Trial Service, a New Integrated Molecular Evaluation that Leverages Artificial Intelligence to Rapidly Match Cancer Patients to Clinical Trials
June 03, 2019 10:30 ET
|
Tempus
CHICAGO, June 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announced today a...
Tempus Announces New Initiative to Support Physicians Efforts to Deliver Personalized Medicine
May 08, 2018 13:27 ET
|
Tempus
CHICAGO, May 08, 2018 (GLOBE NEWSWIRE) -- Tempus today announced a new initiative that will allow physicians to sequence a second patient sample without additional charge, removing a barrier that...